Your search returned 52 studies. (Get alerts for new studies):
- Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
Conditions: Colorectal Cancer
Location: Anchorage, Alaska
- Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
Conditions: Colorectal Cancer
Location: Anchorage, Alaska
- Sorafenib and Temsirolimus in Treating Patients With Recurrent Glioblastoma
Conditions: Brain and Central Nervous System Tumors
Location: Anchorage, Alaska
- Carboplatin and Paclitaxel With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Malignant Tumor of Peritoneum
Location: Anchorage, Alaska
- Study of New Implantable Loop Recorder
Conditions: Tachyarrhythmias - Syncope
Location: Anchorage, Alaska
- Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma
Conditions: Brain and Central Nervous System Tumors
Location: Anchorage, Alaska
- Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer
Conditions: Bladder Cancer
Location: Anchorage, Alaska
- Compassionate Use of Mepolizumab in Subjects With Hypereosinophilic Syndrome (HES)
Conditions: Hypereosinophilic Syndrome
Location: Anchorage, Alaska
- Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer
Conditions: Prostate Cancer
Location: Anchorage, Alaska
- Efficacy and Safety of Zoledronic Acid ( Every 4 Weeks vs. Every 12 Weeks) in Patients With Documented Bone Metastases From Bone Cancer
Conditions: Breast Cancer
Location: Anchorage, Alaska
- Efficacy and Safety of Zoledronic Acid ( Every 4 Weeks vs. Every 12 Weeks) in Patients With Documented Bone Metastases From Bone Cancer
Conditions: Breast Cancer
Location: Anchorage, Alaska
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Conditions: Lung Cancer
Location: Anchorage, Alaska
- EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
Conditions: Neoplasms, Breast
Location: Anchorage, Alaska
- Cisplatin and Radiation Therapy With or Without Erlotinib Hydrochloride in Treating Patients With Stage III or Stage IV Head and Neck Cancer
Conditions: Stage III Squamous Cell Carcinoma of the Hypopharynx - Stage III Squamous Cell Carcinoma of the Larynx - Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity - Stage III Squamous Cell Carcinoma of the Nasopharynx - Stage III Squamous Cell Carcinom
Location: Anchorage, Alaska
- Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer
Conditions: Prostate Cancer
Location: Anchorage, Alaska
- A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
Conditions: Atopic Dermatitis
Location: Anchorage, Alaska
- Sunitinib Malate, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide Before Surgery in Treating Patients With Stage IIB-IIIC Breast Cancer
Conditions: Inflammatory Breast Cancer - Male Breast Cancer - Stage II Breast Cancer - Stage IIIA Breast Cancer - Stage IIIB Breast Cancer - Stage IIIC Breast Cancer
Location: Anchorage, Alaska
- Sunitinib Malate, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide Before Surgery in Treating Patients With Stage IIB-IIIC Breast Cancer
Conditions: Inflammatory Breast Cancer - Male Breast Cancer - Stage II Breast Cancer - Stage IIIA Breast Cancer - Stage IIIB Breast Cancer - Stage IIIC Breast Cancer
Location: Anchorage, Alaska
- Evaluating the Effectiveness of the LifeVest Defibrillator and Improving Methods for Determining the Use of Implantable Cardioverter Defibrillators
Conditions: Death, Sudden, Cardiac - Myocardial Infarction - Arrhythmias, Cardiac
Location: Anchorage, Alaska
- Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
Location: Anchorage, Alaska
- Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
Conditions: Lung Neoplasm - Carcinoma Non-small Cell Lung Cancer Stage IIIA - Carcinoma Non-small Cell Lung Cancer Stage IIIB - Carcinoma Non-small Cell Lung Cancer Stage IV
Location: Anchorage, Alaska
- Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab Followed By Bevacizumab and Erlotinib Hydrochloride in Treating Patients With M
Conditions: Estrogen Receptor-negative Breast Cancer - HER2-negative Breast Cancer - Progesterone Receptor-negative Breast Cancer - Stage IV Breast Cancer - Triple-negative Breast Cancer
Location: Anchorage, Alaska
- Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab Followed By Bevacizumab and Erlotinib Hydrochloride in Treating Patients With M
Conditions: Estrogen Receptor-negative Breast Cancer - HER2-negative Breast Cancer - Progesterone Receptor-negative Breast Cancer - Stage IV Breast Cancer - Triple-negative Breast Cancer
Location: Anchorage, Alaska
- A Study to Assess Whether PDE5 Inhibitors Increase the Chance of Triggering the Onset of Acute NAION
Conditions: Optic Neuropathy, Ischemic
Location: Anchorage, Alaska
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
Conditions: Breast Cancer
Location: Anchorage, Alaska
- Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II End
Conditions: Endometrial Cancer - Fatigue - Neurotoxicity
Location: Anchorage, Alaska
- Study of Immunotherapy to Treat Advanced Prostate Cancer
Conditions: Prostate Cancer
Location: Anchorage, Alaska
- Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Conditions: Breast Cancer - Lung Cancer - Metastatic Cancer - Multiple Myeloma and Plasma Cell Neoplasm - Prostate Cancer - Unspecified Adult Solid Tumor, Protocol Specific
Location: Anchorage, Alaska
- A Study to Evaluate the Safety of 12 Weeks of Dosing With GW856553 and Its Effects on Inflammatory Markers, Infarct Size, and Cardiac Function in Subj
Conditions: Acute Coronary Syndrome
Location: Anchorage, Alaska
- Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Anchorage, Alaska
- Longitudinal Surveillance Registry (LSR) of ACUITY Spiral
Conditions: Heart Failure
Location: Anchorage, Alaska
- Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer
Conditions: Liver Cancer
Location: Anchorage, Alaska
- Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
Conditions: Prostate Cancer
Location: Anchorage, Alaska
- Treatment With Adenosine Diphosphate (ADP) Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome
Conditions: Acute Coronary Syndrome
Location: Anchorage, Alaska
- A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer
Conditions: Breast Cancer
Location: Anchorage, Alaska
- PRE-DETERMINE Cohort Study
Conditions: Coronary Artery Disease - Left Ventricular Dysfunction - Sudden Cardiac Death
Location: Anchorage, Alaska
- Study Comparing Orteronel Plus Prednisone in Patients With Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer
Conditions: Prostate Cancer
Location: Anchorage, Alaska
- Study Comparing Orteronel Plus Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer
Conditions: Prostate Cancer
Location: Anchorage, Alaska
- Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Sub
Conditions: Bladder Neoplasm - Intravesical Drug Administration - Neoplasm Recurrence, Local - Transitional Cell, Carcinoma - Carcinoma in Situ - Mycobacterium
Location: Anchorage, Alaska
- Factors Associated With Mortality in Neonates
Conditions: Neonatal Mortality
Location: Anchorage, Alaska
- Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer
Conditions: Breast Cancer
Location: Anchorage, Alaska
- A Study of Ramucirumab in Patients With Gastric, Esophageal and Gastroesophageal Cancer
Conditions: Stomach Cancer - Esophageal Cancer
Location: Anchorage, Alaska
- Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
Conditions: Breast Cancer
Location: Anchorage, Alaska
- Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
Conditions: Breast Cancer
Location: Anchorage, Alaska
- Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
Conditions: Breast Cancer
Location: Anchorage, Alaska
- A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Conditions: Prostatic Neoplasms
Location: Anchorage, Alaska
- Radiation Therapy With Cisplatin or Cetuximab in Treating Patients With Oropharyngeal Cancer
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Anchorage, Alaska
- A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
Conditions: Prostate Cancer Metastatic
Location: Anchorage, Alaska
- Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events)
Conditions: Atherosclerosis
Location: Anchorage, Alaska
- PET-Directed Therapy in Treating Patients With Limited-Stage Diffuse Large B-Cell Lymphoma
Conditions: Lymphoma
Location: Anchorage, Alaska
- Vest Prevention of Early Sudden Death Trial and VEST Registry
Conditions: Myocardial Infarction - Ventricular Dysfunction - Sudden Death - Ventricular Tachycardia - Ventricular Fibrillation
Location: Anchorage, Alaska
- Caris Biorepository Research Protocol
Conditions: Cancer
Location: Anchorage, Alaska
|